S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
NVDA   195.09 (-0.27%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
NVDA   195.09 (-0.27%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
DIS   131.13 (-0.96%)
Log in

ProPhase Labs Stock Price, News & Analysis (NASDAQ:PRPH)

$1.82
-0.03 (-1.62 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
$1.75
Now: $1.83
$1.98
50-Day Range
$1.78
MA: $1.90
$2.05
52-Week Range
$1.63
Now: $1.83
$4.00
Volume1,955 shs
Average Volume444 shs
Market Capitalization$21.10 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.03
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter(OTC) consumer healthcare products, dietary supplements, and other remedies in the United States. The company offers TK Supplements product line include Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support; and Super ProstaFlow+ for prostate and urinary health. In addition, the company provides contract manufacturing services of OTC healthcare and dietary supplements products. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRPH
CUSIPN/A
Phone215-345-0919

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.13 million
Book Value$1.43 per share

Profitability

Net Income$-1,740,000.00

Miscellaneous

Employees47
Market Cap$21.10 million
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable

Receive PRPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter.


ProPhase Labs (NASDAQ:PRPH) Frequently Asked Questions

What is ProPhase Labs' stock symbol?

ProPhase Labs trades on the NASDAQ under the ticker symbol "PRPH."

How often does ProPhase Labs pay dividends? What is the dividend yield for ProPhase Labs?

ProPhase Labs announced a special dividend on Thursday, December 27th. Stockholders of record on Thursday, January 10th will be paid a dividend of $0.25 per share on Thursday, January 24th. The ex-dividend date of this dividend is Wednesday, January 9th. View ProPhase Labs' Dividend History.

How will ProPhase Labs' stock buyback program work?

ProPhase Labs declared that its board has approved a share buyback plan on Saturday, November 11th 2017, which permits the company to buyback 1,700,000 shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through a tender offer. Stock buyback plans are often an indication that the company's board believes its stock is undervalued.

How were ProPhase Labs' earnings last quarter?

ProPhase Labs Inc (NASDAQ:PRPH) issued its quarterly earnings data on Monday, August, 12th. The company reported ($0.11) EPS for the quarter. The company earned $1.65 million during the quarter. ProPhase Labs had a negative net margin of 35.98% and a negative return on equity of 21.71%. View ProPhase Labs' Earnings History.

When is ProPhase Labs' next earnings date?

ProPhase Labs is scheduled to release their next quarterly earnings announcement on Wednesday, November 13th 2019. View Earnings Estimates for ProPhase Labs.

Has ProPhase Labs been receiving favorable news coverage?

News coverage about PRPH stock has trended somewhat positive on Wednesday, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ProPhase Labs earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for ProPhase Labs.

Are investors shorting ProPhase Labs?

ProPhase Labs saw a decrease in short interest during the month of September. As of September 30th, there was short interest totalling 20,000 shares, a decrease of 6.5% from the August 30th total of 21,400 shares. Based on an average daily trading volume, of 3,600 shares, the short-interest ratio is presently 5.6 days. Approximately 0.2% of the shares of the company are short sold. View ProPhase Labs' Current Options Chain.

Who are some of ProPhase Labs' key competitors?

What other stocks do shareholders of ProPhase Labs own?

Who are ProPhase Labs' key executives?

ProPhase Labs' management team includes the folowing people:
  • Mr. Ted William Karkus, Chairman & CEO (Age 60)
  • Ms. Monica Brady, CFO & Chief Accounting Officer (Age 42)

How do I buy shares of ProPhase Labs?

Shares of PRPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ProPhase Labs' stock price today?

One share of PRPH stock can currently be purchased for approximately $1.83.

How big of a company is ProPhase Labs?

ProPhase Labs has a market capitalization of $21.10 million and generates $13.13 million in revenue each year. ProPhase Labs employs 47 workers across the globe.View Additional Information About ProPhase Labs.

What is ProPhase Labs' official website?

The official website for ProPhase Labs is http://www.prophaselabs.com/.

How can I contact ProPhase Labs?

ProPhase Labs' mailing address is 621 NORTH SHADY RETREAT ROAD, DOYLESTOWN PA, 18901. The company can be reached via phone at 215-345-0919 or via email at [email protected]


MarketBeat Community Rating for ProPhase Labs (NASDAQ PRPH)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  84 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  194
MarketBeat's community ratings are surveys of what our community members think about ProPhase Labs and other stocks. Vote "Outperform" if you believe PRPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel